FDX1 and adrenal cortex carcinoma: Likewise, KM analysis of PFI showed that FDX1 was a protective factor in patients with KIRC, LIHC, and THCA but was a risk factor in patients with ACC, HNSC, and LGG (Figures 6B–G).